German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors

H Dralle, TJ Musholt, J Schabram, T Steinmüller… - … archives of surgery, 2013 - Springer
Introduction Over the past years, the incidence of thyroid cancer has surged not only in
Germany but also in other countries of the Western hemisphere. This surge was first and …

Liquid-based cytology in fine-needle aspiration biopsies of the thyroid gland

G Fadda, ED Rossi - Acta cytologica, 2011 - karger.com
Objectives: Fine-needle aspiration biopsy is regarded as the most important diagnostic tool
for thyroid lesions because of its simplicity, safety, and cost-effectiveness. However, its …

Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy

I Ganly, J Ricarte Filho, S Eng… - The Journal of …, 2013 - academic.oup.com
Context: Hurthle cell cancer (HCC) is an understudied cancer with poor prognosis.
Objective: Our objective was to elucidate the genomic foundations of HCC. Design and …

Hurthle cell carcinoma: a population‐level analysis of 3311 patients

P Goffredo, SA Roman, JA Sosa - Cancer, 2013 - Wiley Online Library
BACKGROUND: Hurthle cell carcinoma (HCC) is an uncommon and more aggressive
thyroid cancer. To date, there is a paucity of data at a population level. In this study …

Castration-induced bone loss triggers growth of disseminated prostate cancer cells in bone

PD Ottewell, N Wang, J Meek… - Endocrine-related …, 2014 - erc.bioscientifica.com
Up to 90% of patients with castrate-resistant prostate cancer develop bone metastases, and
the majority of these men have received androgen deprivation therapy known to cause bone …

Pitfalls in thyroid cytopathology

ED Rossi, AJ Adeniran… - Surgical pathology …, 2019 - surgpath.theclinics.com
Fine-needle aspiration (FNA) is among the first diagnostic tools used in the evaluation of
thyroid nodules. It has the ability to triage patients with benign and malignant lesions, thus …

Hürthle cell carcinoma: current perspectives

S Ahmadi, M Stang, XS Jiang, JA Sosa - OncoTargets and therapy, 2016 - Taylor & Francis
Hürthle cell carcinoma (HCC) can present either as a minimally invasive or as a widely
invasive tumor. HCC generally has a more aggressive clinical behavior compared with the …

Thyroid Hürthle cell carcinoma: clinical, pathological, and molecular features

S Kure, R Ohashi - Cancers, 2020 - mdpi.com
Simple Summary Hürthle cell carcinoma (HCC) represents 3–4% of thyroid carcinoma
cases. It is characterized by its large, granular and eosinophilic cytoplasm, due to an …

Thyroid FNAC: Causes of false‐positive results

DC Malheiros, S Canberk, DN Poller… - Cytopathology, 2018 - Wiley Online Library
In this paper, we aim to focus on false positive results in the evaluation of thyroid aspirations,
covering cystic, inflammatory, follicular and oncocytic lesions, papillary carcinoma, and …

Oncocytic papillary thyroid carcinoma and oncocytic poorly differentiated thyroid carcinoma: clinical features, uptake, and response to radioactive iodine therapy, and …

J Lukovic, I Petrovic, Z Liu, SM Armstrong… - Frontiers in …, 2021 - frontiersin.org
Objective The main objective of this study was to review the clinicopathologic characteristics
and outcome of patients with oncocytic papillary thyroid carcinoma (PTC) and oncocytic …